These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7865511)

  • 21. [Clinical significance of electrophysiologic drug testing in the longterm therapy of class I, III and IV antiarrhythmic drugs for recurrent ventricular tachyarrhythmia].
    Kasanuki H; Ohnishi S; Amamiya K; Umemura J; Shoda M; Hosoda S
    Jpn Circ J; 1992; 56 Suppl 5():1458-61. PubMed ID: 1291742
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of tricyclic antidepressant-induced ventricular tachyarrhythmia by a specific bradycardic agent in a canine model.
    Ansel GM; Meimer JP; Nelson SD
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):256-60. PubMed ID: 7526057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias.
    Liem LB; Swerdlow CD
    Am J Cardiol; 1988 Sep; 62(9):611-6. PubMed ID: 3414554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is intermittent dobutamine treatment beneficial in patients with dilated cardiomyopathy?].
    Eryol NK; Güven M; Topsakal R; Abaci A; Başar E; Ergin A; Cetin S
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):220-3. PubMed ID: 12223320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophilic explant carditis with eosinophilia: ?Hypersensitivity to dobutamine infusion.
    Spear GS
    J Heart Lung Transplant; 1995; 14(4):755-60. PubMed ID: 7578186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Slow ventricular tachycardia caused by naftidrofuryl overdose (naftidrofuryl and ventricular tachycardia)].
    Malaterre HR; Ferracci A; Ebagosti A; Faugier JP; Charles D; Levy S
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):379-81. PubMed ID: 1285624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torsade de pointes ventricular tachycardia during low dose intermittent dobutamine treatment in a patient with dilated cardiomyopathy and congestive heart failure.
    Vecchia L; Ometto R; Finocchi G; Vincenzi M
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):397-9. PubMed ID: 10087562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN
    J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic management of recurrent ventricular tachycardia in acute and chronic ischemic heart disease.
    Josephson ME; Kastor JA; Horowitz LN
    Cardiovasc Clin; 1980; 11(1):35-55. PubMed ID: 7002305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium therapy for intractable ventricular tachyarrhythmias in normomagnesemic patients.
    Iseri LT; Chung P; Tobis J
    West J Med; 1983 Jun; 138(6):823-8. PubMed ID: 6613108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia.
    Kay GN; Epstein AE; Bubien RS; Anderson PG; Dailey SM; Plumb VJ
    J Am Coll Cardiol; 1992 Jan; 19(1):159-68. PubMed ID: 1729328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of ventricular arrhythmias using electrophysiologic techniques.
    Spielman SR; Likoff MJ; Kutalek SP
    Cardiol Clin; 1986 Aug; 4(3):507-13. PubMed ID: 3530472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia.
    Hilton TC; Fredman C; Holt DJ; Bjerregaard P; Ira GH; Janosik DL
    Clin Cardiol; 1992 Mar; 15(3):176-80. PubMed ID: 1551265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cardiac arrhythmias during dobutamine pharmacologic stress testing in nuclear cardiology as related to the presence or absence of baseline arrhythmias.
    Hanson MW; Morris EI; Borges-Neto S; DeLong DM
    J Nucl Cardiol; 1997; 4(5):372-8. PubMed ID: 9362013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest.
    Freedman RA; Swerdlow CD; Soderholm-Difatte V; Mason JW
    Am J Cardiol; 1988 Mar; 61(8):578-82. PubMed ID: 3344682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of ventricular function in infants and children. Response to dobutamine infusion.
    Hurwitz RA; Siddiqui A; Caldwell RL; Weetman RM; Girod DA
    Clin Nucl Med; 1990 Aug; 15(8):556-9. PubMed ID: 2390819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained nonischemic ventricular tachycardia during dobutamine stress echocardiography.
    Madu EC; Price A; Harris T; Badran H; Rouse C; Ramanathan KB
    Cardiology; 1996; 87(1):82-5. PubMed ID: 8631052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmias associated with intermittent outpatient dobutamine infusion.
    David S; Zaks JM
    Angiology; 1986 Feb; 37(2):86-91. PubMed ID: 3954157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of inducible ventricular tachycardia in patients with clinical ventricular tachyarrhythmia and no apparent structural heart disease.
    Brodsky MA; Orlov MV; Winters RJ; Allen BJ
    Am Heart J; 1993 Nov; 126(5):1113-20. PubMed ID: 8237753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.